To mark World Heart Day and the launch of the first European Screening Week, the European Commission has adopted a proposal for a Council Recommendation on cardiovascular health screening. Its aim is to safeguard the health of European citizens by improving early detection and screening, and ultimately reducing premature deaths from cardiovascular disease. Cardiovascular diseases […]
Read More
The EU is driving forward the Global Health Resilience Initiative with new investments in the Global Gateway programme in Africa and Latin America
As part of the High-Level Week of the United Nations General Assembly, the European Commission has announced three new investments under the Global Gateway programme, which launch the EU’s Global Health Resilience Initiative in partner countries. The package includes an EU guarantee of €63.5 million aimed at mobilising private investment in health and nutrition companies […]
Read More
Commission and EU Drugs Agency present the 2026 European Drug Report
Last June 9, Commissioner for Internal Affairs and Migration, Magnus Brunner and the European Union Drugs Agency (EUDA) are presenting the 2026 European Drug Report 2026, with the latest evidence on the state of the drugs situation in Europe. Based on data from 29 countries (EU-27, Norway and Türkiye), the report shows that drugs have an increasingly negative impact on European health and security as they […]
Read More
The EU and the WHO are stepping up their efforts to respond to the Ebola outbreak in the Democratic Republic of the Congo and Uganda
The European Union and the World Health Organisation (WHO) are stepping up their cooperation to support national authorities in responding to the Ebola outbreaks currently occurring in the Democratic Republic of the Congo (DRC) and Uganda, with the aim of rapidly containing transmission, protecting communities and strengthening preparedness in the region, ultimately saving lives. Thanks […]
Read More
The Commission welcomes the political agreement on the Critical Medicines Act
The European Commission welcomes the historic political agreement on the Critical Medicines Act (CMA) reached by the Council and the European Parliament. This agreement marks a significant milestone in strengthening the resilience of the European healthcare sector, preventing medicine shortages and improving the security of supply of essential medicines across the EU. The CMA will […]
Read More
The Commission announces new global health commitments at the ‘One Health’ Summit
The European Commission plans to allocate €700 million to the Global Fund to fight HIV, tuberculosis and malaria. It will also invest €46.5 million to strengthen public health security in Africa and Europe, with a particular focus on combating antimicrobial resistance (AMR), and €50 million in research and development to tackle AMR and neglected tropical […]
Read More
Commission evaluation of the EU tobacco control framework highlights progress and emerging public health challenges
The European Commission has published last April 2 its evaluation of the EU tobacco control framework. It assesses the effectiveness, efficiency and relevance of the Tobacco Products Directive and Tobacco Advertising Directive in protecting public health and ensuring the smooth functioning of the internal market. The findings show that the EU rules on tobacco control have […]
Read More
The EU and Nigeria open negotiations on a bilateral agreement on cooperation in science and technology
The European Commission, on behalf of the EU, and the Federal Republic of Nigeria have started negotiations for a bilateral Science and Technology Cooperation Agreement. The aim is to boost cooperation in research and innovation, in line with the conclusions of the 2023 EU-Nigeria Strategic Dialogue and the 2024 EU-Nigeria Summit. A bilateral agreement on […]
Read More
Commission invests €225 million to deliver next-generation influenza vaccines
The European Union is committing €225 million to speed up the development of next-generation flu vaccines that will offer protection across a wider range of influenza variants and quickly adapted if a pandemic strain emerges. It marks the first time the Commission will be using pre-commercial procurement to advance products through clinical trials, ensuring they […]
Read More